Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01389206 · ClinicalTrials.gov registry record
Pulmonary Arterial Hypertension Quality Enhancement Research Initiative Extension Program
A clinical trial, sponsored by Actelion.
- Completed
- Registry status
- 797
- Enrollment target
NCT01389206 is a clinical trial that has completed, run by Actelion. The registered enrollment target is 797 participants.
The verdict
NCT01389206 has completed, sponsored by Actelion.
- COMPLETED
- Registry status
- 797 participants
- Enrollment target
Study Summary
Knowledge Translation Program for the guidelines and evidence-based management of PAH patients
Interventions
- DRUG observational study with patients treated with Tracleer, Ventavis, Veletri, Opsumit and/or Uptravi
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 797 participants |
| Start Date | 2011-06-01 |
| Est. Completion | 2018-04-10 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01389206
The ClinicalTrials.gov registry entry for NCT01389206 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 797 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Actelion, which has 63 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which observational study with patients treated with Tracleer, Ventavis, Veletri, Opsumit and/or Uptravi is the first listed.
NCT01389206 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01389206 about?
NCT01389206 is a clinical study titled "Pulmonary Arterial Hypertension Quality Enhancement Research Initiative Extension Program". Knowledge Translation Program for the guidelines and evidence-based management of PAH patients
What is the current status of trial NCT01389206?
This trial is currently completed. The enrollment target is 797 participants. The study started on 2011-06-01. Estimated completion is 2018-04-10.
What interventions are being tested in trial NCT01389206?
The interventions under investigation include: observational study with patients treated with Tracleer, Ventavis, Veletri, Opsumit and/or Uptravi (DRUG).
Who is sponsoring clinical trial NCT01389206?
This trial is sponsored by Actelion, which has 63 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.